Clinical Study

A Randomized, Double-Blind, Placebo-Controlled Safety Study Of Ds-5565 For Treatment Of Pain Due To Fibromyalgia In Subjects With Chronic Kidney Disease.

Posted Date: Apr 7, 2017

  • Investigator: Lesley Arnold
  • Co-Investigator: Gayathri Pulapaka
  • Specialties:
  • Type of Study: Drug

The purpose of this study is to gather information and test the safety and tolerability of an investigational drug compared to a placebo (inactive substance) that may help treat pain caused by fibromyalgia in people with reduced kidney function.

Criteria:

Adults 18 Years Of Age And Older With Fibromyalgia And Reduced Kidney Function May Be Eligible To Participate

Keywords:

Kidney Disease, Fibromyalgia, Null, Null, Null

For More Information:

Kerri Earles
513-558-7104
kerri.earles@uc.edu

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.